NVN LIQUIDATION, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0008 USD | 0.00% |
|
0.00% | +60.00% |
| Jan. 17 | First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc. | CI |
| 2023 | Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc. | CI |
Chart calendar NVN Liquidation, Inc.
26b293e7acaddc9fcf6290799.WJB7ynwIzTjNKOcecZCHDM31ojB6GP_p59KN75qGSzE.C_QVlRZ7nwGSGZ0sRenCaK7GyggfR7vcnbDsq6vQLUs0pAGELlr7b_hQ1w~67c1cb455e9ed596f65353de7607f8e7
Past events on NVN Liquidation, Inc.
| 2024-03-26 | Q4 2023 Earnings Release (Projected) |
| 2023-06-06 09:30 am | Annual General Meeting |
| 2023-05-15 08:30 am | Q1 2023 Earnings Call |
| 2023-05-15 06:45 am | Q1 2023 Earnings Release |
| 2023-03-30 08:30 am | Q4 2022 Earnings Call |
| 2023-03-30 06:30 am | Q4 2022 Earnings Release |
| 2023-03-14 10:40 am | Oppenheimer Healthcare Conference |
| 2023-01-19 12:00 pm | Virtual Investor 2023 Companies to Watch |
| 2022-12-08 11:00 am | Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference |
| 2022-11-14 08:30 am | Q3 2022 Earnings Call |
| 2022-11-14 07:00 am | Q3 2022 Earnings Release |
| 2022-10-19 | Fall Clinical Dermatology Conference - Patient and Caregiver Experiences with Molluscum Contagiosum |
| 2022-10-19 | Fall Clinical Dermatology Conference - Improving Patient Acceptability and Adherence in Psoriasis Tr |
| 2022-10-19 | Fall Clinical Dermatology Conference - Calciprotriene (CAL) and Bethamethasone Dipropionate (BDP) Cr |
| 2022-10-19 | Fall Clinical Dermatology Conference - Enhanced Skin Deposition of Betamethasone Dipropionate into t |
| 2022-10-19 | Fall Clinical Dermatology Conference - Nigel Crutchley |
| 2022-10-19 | Fall Clinical Dermatology Conference - PAD Technology |
| 2022-10-19 | Fall Clinical Dermatology Conference - Efficacy and Safety of Topical Nitric Oxide-releasing Berdazi |
| 2022-10-19 | Fall Clinical Dermatology Conference - Calcipotriene (CAL) and Betamethasone Dipropionate (BDP) |
| 2022-09-08 | Skin Of Color Update Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 5,99 2,63 127.71% | 4,90 4,31 13.64% | 4,92 5,09 -3.3% | 2,96 3,06 -3.21% | 23,7 19,4 22.35% |
|
EBITDA Million USD | Released Forecast Spread | -26,9 -31,7 15.28% | -28,7 -32,1 10.85% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -28,6 -33,2 13.98% | -30,7 -35,3 13.06% | -26,2 -29,1 10.02% | -29,9 -29,9 -0.14% | -34,2 -40,6 15.6% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -12,7 -28,0 54.72% | -30,6 -45,6 32.74% | -29,3 -31,1 5.85% | -29,7 -29,6 -0.27% | -31,3 -38,2 17.93% |
|
Net income Million USD | Released Forecast Spread | -12,7 -28,0 54.72% | -30,6 -45,6 32.74% | -29,3 -31,2 5.98% | -29,7 -29,6 -0.27% | -31,3 -37,7 17.03% |
|
EPS USD | Released Forecast Spread | -4,90 -10,9 54.91% | -11,7 -17,3 32.37% | -3,00 -3,20 6.25% | -1,74 -1,74 0.23% | -1,42 -1,52 6.37% |
| Announcement Date | 27/03/19 | 24/02/20 | 24/02/21 | 18/02/22 | 30/03/23 |
Quarterly results
| Fiscal Period | December | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,82 0,96 -14.46% | 0,75 0,83 -10% | 0,74 0,75 -1.99% | 0,66 0,74 -11.25% | 1,93 1,35 42.37% | 6,16 6,60 -6.65% | 5,12 6,28 -18.54% | 10,5 6,15 70.29% | 3,17 6,19 -48.85% |
|
EBIT Million USD | Released Forecast Spread | -8,29 -7,82 -5.93% | -7,06 -8,12 13.1% | -6,48 -7,89 17.84% | -8,09 -7,97 -1.5% | -13,2 -11,5 -14.99% | -8,29 -11,5 28% | -9,80 -8,73 -12.36% | -2,91 -9,37 68.91% | -13,8 -8,28 -67.14% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,95 -7,81 -14.59% | -6,02 -8,12 25.78% | -6,48 -8,08 19.72% | -8,23 -8,08 -1.86% | -13,4 -12,1 -10.63% | -8,88 -12,1 26.38% | -6,03 -8,99 32.92% | -3,02 -9,51 68.21% | -14,1 -8,75 -60.76% |
|
Net income Million USD | Released Forecast Spread | -8,95 -7,81 -14.59% | -6,02 -8,12 25.78% | -6,48 -7,89 17.77% | -8,23 -7,97 -3.29% | -13,4 -11,5 -16.51% | -8,88 -11,8 25.03% | -6,03 -8,91 32.3% | -3,02 -9,46 68.05% | -14,1 -8,48 -66.59% |
|
EPS USD | Released Forecast Spread | -0,60 -0,50 -20% | -0,39 -0,53 26.42% | -0,34 -0,42 19.05% | -0,44 -0,42 -4.76% | -0,71 -0,61 -17.36% | -0,44 -0,60 26.05% | -0,25 -0,39 36.44% | -0,09 -0,30 69.83% | -0,54 -0,32 -68.75% |
| Announcement Date | 11/05/21 | 12/08/21 | 10/11/21 | 18/02/22 | 16/05/22 | 11/08/22 | 14/11/22 | 30/03/23 | 15/05/23 |
More events
Past sector events for NVN Liquidation, Inc.
| 2024-02-12 | E7 GROUP: Q4 2023 Earnings Release |
| 2024-02-08 06:58 am | PERELLA WEINBERG PARTNERS: Q4 2023 Earnings Release |
| 2023-11-09 | E7 GROUP: Q3 2023 Earnings Release |
| 2023-11-07 07:00 am | PERELLA WEINBERG PARTNERS: Q3 2023 Earnings Release |
| 2023-08-10 | E7 GROUP: Q2 2023 Earnings Release |
| 2023-08-03 06:59 am | PERELLA WEINBERG PARTNERS: Q2 2023 Earnings Release |
| 2023-05-09 | E7 GROUP: Q1 2023 Earnings Release |
| 2023-05-04 07:00 am | PERELLA WEINBERG PARTNERS: Q1 2023 Earnings Release |
| 2023-02-23 | E7 GROUP: Q4 2022 Earnings Release |
| 2023-02-08 | PERELLA WEINBERG PARTNERS: Q4 2022 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVNQ Stock
- Calendar NVN Liquidation, Inc.
